Prevalence of chronic kidney disease in a population with type 2 diabetes of a cardiovascular risk program
PDF (Español)
HTML (Español)

Keywords

type 2 diabetes mellitus, chronic kidney disease, prevalence, risk factors, glomerular filtration rate, creatinine.

How to Cite

1.
Laura, Losada Álvarez LM, Serna Flórez J, Duque Valencia JL, Nieto Cárdenas OA. Prevalence of chronic kidney disease in a population with type 2 diabetes of a cardiovascular risk program. Rev. Colomb. Nefrol. [Internet]. 2020 Aug. 4 [cited 2024 Mar. 28];7(2). Available from: https://revistanefrologia.org/index.php/rcn/article/view/481

Abstract

Introduction: In Colombia, the prevalence of type 2 diabetes mellitus (DM2) is 7-9%, this being the main cause of end-stage renal disease in the world4.In the municipality of Armenia, the prevalence of the population suffering from DM2 with chronic kidney disease (CKD) and the risk factors related to its development are unknown.

Objective: To determine the prevalence and risk factors of developing chronic kidney disease (CKD) in a population with type 2 diabetes, consultants to a cardiovascular risk program of an IPS of Armenia, Colombia, during the year 2017.

Methods: Descriptive cross-sectional study with 232 patients. The variables were described by measures of central tendency and 95 % confidence intervals, ANOVA and Chi square tests were performed for the numerical and categorical variables respectively, multiple regression and logistic regression, with a value of P <0.05.

Results: The prevalence of diabetes was 34.14 % and CKD varies between 22.41-38.79 % according to the equation used. 69.83 % are in normoalbuminuria, 25 % in microalbuminuria and 5.17 % in macroalbuminuria. The risk factors identified for CKD were: age (Cockcroft-Gault and CKD-EPI p <0.001; MDRD p = 0.012), abdominal perimeter (Cockcroft-gault p <0.001; MDRD p = 0.028; CKD-EPI p = 0.011), creatinine level (Cockcroft-gault, MDRD, CKD-EPI p <0.001) and sedentary lifestyle (Cockcroft-gault p = 0.046). The most adequate equations for early identification of CKD in this population are CKD-EPI (R2 = 85.74 %) and Cockcroft- gault (R2 = 85.43 %), with a prognostic value of 95.68 % and 93, 96 % respectively.

Conclusion: The prevalence of CKD varies between 22.41 % and 38.79 %, depending on the equation used. The risk factors for developing CKD are age, creatinine level, abdominal perimeter and sedentary lifestyle. It is proposed that for this population the Cockcroft-Gault and CKD-EPI equations are the most adequate to identify CKD.

https://doi.org/10.22265/acnef.7.2.481
PDF (Español)
HTML (Español)

References

Asociación latinoamericana de diabetes (ALAD). Guías ALAD sobre el diagnóstico, control y tratamiento de la diabetes mellitus tipo 2 con medicina basada en evidencia Edición 2013. Rev de la ALAD. 2013.

Standard of medical care in diabetes - 2017: Summary of Revisions. Diabetes Care. 2017;40(Suppl 1): s4-5. https://doi.org/10.2337/dc17-S003.

Organización Mundial de la Salud (OMS). Informe mundial sobre la diabetes. Ginebra: OMS; 2016 [citado Junio 18 de 2018]. Disponible en: https://www.who.int/diabetes/global-report/es/

Colombia. Ministerio de Salud y Protección Social. Guía de práctica clínica para el diagnóstico, tratamiento y seguimiento de la diabetes mellitus tipo 2 en la población mayor de 18 años. Guía No. GPC-2015-51.Bogotá D.C.: Minsalud; 2016.

Ojeda G, Ordóñez M, Ochoa LH. Encuesta Nacional de Demografía y Salud. Bogotá D.C.: Profamilia; 2010.

Álvarez-Ceballos JC, Álvarez-Muñoz AM, Carvajal-Gutiérrez W, González MM, Duque JL, Nieto-Cárdenas OA. Determinación del riesgo cardiovascular en una población. Rev. Colomb. Cardiol. 2017;24(4):334-41. https://doi.org/10.1016/j.rccar.2016.08.002.

Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2012 Clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl. 2013;3:S6-308.

Colombia. Ministerio de Salud y Protección Social (Minsalud). Guía de práctica clínica para el diagnóstico y tratamiento de la enfermedad renal crónica (adopción). Bogotá D.C.: Minsalud; 2016.

Lopera Medina M.M. La enfermedad renal crónica en Colombia: necesidades en salud y respuesta del Sistema General de Seguridad Social en Salud. Revista Gerencia y Políticas de Salud. 2016;15(30): 212-33. http://dx.doi.org/10.11144/Javeriana.rgyps15-30.ercc.

Pérez CM., Soto-Salgado M, Suarez E, Guzmán M, Ortiz AP. High Prevalence of Diabetes and Prediabetes and Their Coexistence with Cardiovascular Risk Factors in a Hispanic Community. J Immigr Minor Health. 2015;17(4):1002-9. https://doi.org/10.1007/s10903-014-0025-8.

McCulloch D, Hayward R. Screening for type 2 diabetes mellitus. Uptodate. [citado Junio 15 de 2018]. Disponible en: https://www.uptodate.com/contents/screening-for-type-2-diabetes-mellitus

Organización Panamericana de la Salud. La OPS/OMS y la Sociedad Latinoamericana de Nefrología llaman a prevenir la enfermedad renal y a mejorar el acceso al tratamiento. Washington, D.C.: OPS;2015 [citado mayo 30 2018]. Disponible en: https://www.paho.org/hq/index.php?option=com_content&view=article&id=10542 %3A2015-opsoms-sociedad-latinoamericana-nefrologia-enfermedad-re-nal-mejorar-tratamiento&catid=740 %3Apress-releases&Itemid=1926&lang=es.

Lloyd H, Li G, Tomlin A, Tilyard MW, Walker R, Schollum J. The Prevalence and Risk Factors for Chronic Kidney Disease in Primary Health Care in the Southern Region of New Zealand. Nephrology (Carlton). 2018;24(3):308-15. https://doi.org/10.1111/nep.13395.

Martínez-Candela J, Sangrós-González J, García-Soidán FJ, Millaruelo-Trillo JM, Díez-Espino J, Bordonaba-Bosque D, et al. Enfermedad renal crónica en España: prevalencia y factores relacionados en personas con diabetes mellitus mayores de 64 años. Nefrología. 2018;38(4):347-458. https://doi.org/10.1016/j.nefro.2017.11.025.

Lee EY, Lee YM, Choi KH, Lee HC, Lee BW, Kim BS. Comparison of Two Creatinine-Based Equations for Predicting Decline in Renal Function in Type 2 Diabetic Patients with Nephropathy in a Korean Population. Int J Endocrinol. 2013;2013:848963. http://dx.doi.org/10.1155/2013/848963.

Zaman SB. Detection of Chronic Kidney Disease by Using Different Equations of Glomerular Filtration Rate in Patients with Type 2 Diabetes Mellitus: A Cross-Sectional Analysis. Cureus. 2017;9(6):e1352. http://dx.doi.org/10.7759/cureus.1352.

Colombia. Gobernación del Quindío, Secretaría de Salud Departamental. Análisis de situación de salud en el modelo de determinantes sociales en salud (ASIS). Armenia: Minsalud; 2016.

Schwandt A, Denkinger M, Fasching P, Pfeifer M, Wagner C, Weiland J, et al. Comparison of MDRD, CKD-EPI, and Cockcroft-Gaultequation in relation to measured glomerular filtration rate among a large cohort with diabetes. J Diabetes Complications. 2017;31(9):1376-83. http://dx.doi.org/10.1016/j.jdiacomp.2017.06.016.

Ji E, Kim YS. Prevalence of chronic kidney disease defined by using CKD-EPI equation and albumin to creatinine ratio in the Korean adult population. Korean J Intern Med. 2016;31(6):1120-30. http://dx.doi.org/10.3904/kjim.2015.193.

Falodia J, Singla MK CKD epidemiology and risk factors. Clin Queries Nephrol. 2012;1(4):249-52. http://dx.doi.org/10.1016/j.cqn.2012.09.004.

Ding C, Yang Z, Wang S, Sun F, Zhan S. The associations of metabolic síndrome with incident hypertension, type 2 diabetes mellitus and chronic kidney disease: A cohort study. Endocrine. 2018;60(2):282-91. https://doi.org/10.1007/s12020-018-1552-1.

Kittiskulnam P, Thokanit NS, Katavetin P, Susanthitaphong P, Srisawat N, Praditpornsilpa K, et al. The magnitude of obesity and metabolic syndrome among diabetic chronic kidney disease population: A nationwide study. PLoS One. 2018;13(5):e0196332. https://doi.org/10.1371/journal.pone.0196332.

Xu L, Yu W, Huang P, Li C, Li Y, Wang M, et al.The age specific association of waist circumference and risk of chronic kidney disease in patients with type 2 diabetes mellitus in Shandong, China. Int J Endocrinol. 2015;2015:715871. http://dx.doi.org/10.1155/2015/715871.

Dunkler D, Kohl M, Teo KK, Heinze G, Dehghan M, Clase CM, et al. Population-Attributable Fractions of Modifiable Lifestyle Factors for CKD and Mortality in Individuals with Type 2 Diabetes: A Cohort Study. Am J Kidney Dis. 2016;68(1):29-40. https://doi.org/10.1053/j.ajkd.2015.12.019.

Nieto-Cárdenas OA., Serna-Flórez J. Filtración glomerular en una comunidad universitaria en Armenia, Colombia. Rev. Colom. Nefrol. 2017;4(2). http://dx.doi.org/10.22265/acnef.4.2.277.

Organización Mundial de la Salud (OMS). Prevención de las enfermedades cardiovasculares: guía de bolsillo para la estimación y el manejo del riesgo cardiovascular. Ginebra: OMS; 2008.

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Copyright (c) 2020 Revista Colombiana de Nefrología

Dimensions


PlumX


Downloads

Download data is not yet available.